within Pharmacolibrary.Drugs.ATC.J;

model J01CF02
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.00011866666666666667,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.011699999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01CF02</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cloxacillin is a beta-lactam antibiotic of the penicillinase-resistant penicillin class. It is mainly used for the treatment of infections caused by penicillinase-producing staphylococci, particularly skin, respiratory tract, bone, and joint infections. Cloxacillin is approved for clinical use and remains a recommended choice for staphylococcal infections in many guidelines.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters of cloxacillin reported in healthy adult volunteers (mixed sexes).</p><h4>References</h4><ol><li><p>Bock, M, et al., &amp; Moser, C (2023). Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 77(2) 242–251. DOI:<a href=&quot;https://doi.org/10.1093/cid/ciad168&quot;>10.1093/cid/ciad168</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/36947131/&quot;>https://pubmed.ncbi.nlm.nih.gov/36947131</a></p></li><li><p>Nergelius, G, et al., &amp; Grubb, A (1997). No effect of diclofenac on the pharmacokinetics of cloxacillin. <i>Pharmacology &amp; toxicology</i> 81(1) 26–30. DOI:<a href=&quot;https://doi.org/10.1111/j.1600-0773.1997.tb00026.x&quot;>10.1111/j.1600-0773.1997.tb00026.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9258981/&quot;>https://pubmed.ncbi.nlm.nih.gov/9258981</a></p></li><li><p>Visser, LG, et al., &amp; van den Broek, PJ (1993). Clinical pharmacokinetics of continuous intravenous administration of penicillins. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 17(3) 491–495. DOI:<a href=&quot;https://doi.org/10.1093/clinids/17.3.491&quot;>10.1093/clinids/17.3.491</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/8218695/&quot;>https://pubmed.ncbi.nlm.nih.gov/8218695</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01CF02;
